QTTB
Q32 Bio Inc.NASDAQHealthcare$6.38-11.60%ClosedMarket Cap: $78.5M
As of 2026-04-06
Valuation
P/E (TTM)
2.63
PEG
0.02
P/B
1.69
P/S
1.29
EV/EBITDA
1.69
DCF Value
$3.21
FCF Yield
-48.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.7%
Operating Margin
31.5%
Net Margin
55.5%
ROE
1630.2%
ROA
48.3%
ROIC
29.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $53.7M | 99.8% | $45.9M | $57.7M | $4.58 | — |
| FY 2025 | $53.7M | 99.3% | $16.9M | $29.8M | $2.42 | — |
| Q3 2025 | $0.00 | NaN% | $-7.6M | $-7.4M | $-0.60 | — |
| Q2 2025 | $0.00 | -Infinity% | $-9.2M | $-9.5M | $-0.78 | — |
| Q1 2025 | $0.00 | NaN% | $-12.2M | $-11.0M | $-0.90 | — |
| Q4 2024 | $0.00 | -Infinity% | $-14.5M | $-14.2M | $-1.16 | — |
| FY 2024 | $0.00 | -Infinity% | $-66.1M | $-47.7M | $-6.58 | — |
| Q3 2024 | $0.00 | NaN% | $-18.8M | $-17.6M | $-1.46 | — |
| Q2 2024 | $0.00 | -Infinity% | $-17.9M | $-17.0M | $-1.42 | — |
| Q1 2024 | $0.00 | -Infinity% | $-14.8M | $1.0M | $0.09 | — |
| Q4 2023 | $-14.7M | 100.0% | $-25.8M | $-27.1M | $-5.00 | — |
| FY 2023 | $-6.7M | 100.0% | $-48.3M | $-53.7M | $-16.70 | — |